Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

CLDXCLDX
9 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in Celldex Therapeutics, Inc.

DRIEHAUS CAPITAL MANAGEMENT LLC holds 989,442 shares of CLDX (Celldex Therapeutics, Inc.), worth $36.8M as of 2026-Q2. This is a new position. CLDX represents 0.2% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$36.8M

Current Shares

989,442

Total Value Change

+$30.9M

Total Shares Change

+587,679

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
989,442
-
$36.8M0.2%$37.21
48
2022-Q2
Exited
0
-100.0%
$00.0%$27.83
0
2022-Q1
Decreased
292,292
-43.3%
$10M0.1%$34.59
0
2021-Q4
Decreased
515,489
-6.5%
$19.9M0.2%$38.90
0
2021-Q3
Decreased
551,065
-5.8%
$29.8M0.4%$51.97
0
2021-Q2
Increased
585,311
+67.8%
$19.6M0.3%$35.37
50
2021-Q1
Decreased
348,840
-11.3%
$7.2M0.1%$19.73
0
2020-Q4
Decreased
393,215
-2.1%
$6.9M0.1%$17.88
0
2020-Q3
New
401,763
-
$6M0.1%$15.19
45

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used